Abstract
The mechanisms by which nerve growth factor (NGF) increases the level of low density lipoprotein receptor-related protein (LRP1) are not known. Administration of nitric oxide synthase (NOS) inhibitors modulates several of the neurotrophic actions of NGF, including TrkA signalling pathway activation, increases in gene expression and neurite outgrowth. The present study investigated whether NGF regulates the transcription of LRP1 as well as the role of NO and the individual TrkA signalling pathways in this action of NGF. PC12 cells were transfected with luciferase reporter constructs containing various sized fragments of the LRP1 promoter and treated with NGF (50 ng/mL) to establish whether NGF altered LRP transcription. NGF significantly increased luciferase activity in all LRP1 promoter construct-transfected cells with the NGF-responsive region of the promoter identified to be present in the first 1000 bp. The non-selective NOS inhibitor Nω-nitro-l-arginine methylester (l-NAME; 20 mM) had no effect on the NGF-mediated increase in luciferase activity, while the inducible NOS selective inhibitor s-methylisothiourea (S-MIU; 2 mM) attenuated the NGF-induced activation of the LRP1 promoter. Pretreatment of PC12 cells with 10 μM bisindolylmaleimide 1 (BIS-1) prevented the NGF-mediated increase in LRP1 promoter activation while 50 μM U0126 partially inhibited this response. In combination with S-MIU, all of the TrkA signalling pathway inhibitors blocked the ability of NGF to increase LRP1 transcription. These data suggest the NGF-mediated increase in LRP1 levels occurs, at least in part, at the level of transcription and that NO and the TrkA signalling pathways cooperate in the modulation of LRP1 transcription.
Similar content being viewed by others
Abbreviations
- α2M:
-
Alpha 2 macroglobulin
- ANOVA:
-
Analysis of variance
- AP-1:
-
Activator protein 1
- APP:
-
Amyloid precursor protein
- ApoE:
-
Apolipoprotein E
- BIS-1:
-
Bisindolylmaleimide 1
- ChAT:
-
Choline acetyltransferase
- ECL:
-
Enhanced chemiluminescence
- LDL:
-
Low density lipoprotein
- l-NAME:
-
Nω-nitro-l-arginine methylester
- LRP1:
-
Low density lipoprotein receptor-related protein
- NGF:
-
Nerve growth factor
- RIPA:
-
Radioimmunoprecipitation assay
- SDS:
-
Sodium dodecyl sulphate
- S-MIU:
-
Methylisothiourea
- TBS:
-
Tris-buffered saline
References
An J, Zhang C, Polavarapu R, Zhang X, Zhang X, Yepes M (2008) Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. Blood 112:2787–2794
Bai S, Ghoshal K, Datta J, Majumder S, Yoon SO, Jacob ST (2005) DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2. Mol Cell Biol 25:751–766
Bapat S, Verkleij A, Post JA (2001) Peroxynitrite activates mitogen-activated protein kinase (MAPK) via a MEK-independent pathway: a role for protein kinase C. FEBS Lett 499:21–26
Baskey JC, Kalisch BE, Davis WL, Meakin SO, Rylett RJ (2002) PC12nnr5 cells expressing TrkA receptors undergo morphological but not cholinergic phenotypic differentiation in response to nerve growth factor. J Neurochem 80:501–511
Beffert U, Morfini G, Bock HH, Reyna H, Brady ST, Herz J (2002) Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem 277:49958–49964
Billon N, Carlisi D, Datto MB, van Grunsven LA, Watt A, Wang XF, Rudkin BB (1999) Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation. Oncogene 18:2872–2882
Binnington JC, Kalisch BE (2007) Nitric oxide synthase inhibitors modulate nerve growth factor-mediated regulation of amyloid precursor protein expression in PC12 cells. J Neurochem 101:422–433
Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I (2000) The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 58:1026–1034
Boucher P, Liu P, Gotthardt M, Hiesberger T, Anderson RG, Herz J (2002) Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J Biol Chem 277:15507–15513
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Brodeur GM, Minturn JR, Ho R, Simpson AM, Iyer R, Varela CR, Light JE, Kolla V, Evans AE (2009) Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res 15:3244–3250
Bu G, Maksymovitch EA, Nerbonne JM, Schwartz AL (1994) Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem 269:18521–18528
Bu G, Sun Y, Schwartz AL, Holtzman DM (1998) Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein receptor-related protein. J Biol Chem 273:13359–13365
Cam JA, Zerbinatti CV, Li Y, Bu GT (2005) Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein. J Biol Chem 280:15464–15470
Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer’s disease. Neuroscience 19:1–28
Cragg CL, MacKinnon JC, Kalisch BE (2012) Nitric oxide synthase inhibitors modulate nerve-growth-factor mediated activation of Akt. ISRN Cell Biol. doi:10.5302/2012/847974
Fagan AM, Bu G, Sun Y, Daugherty A, Holtzman DM (1996) Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem 271:30121–30125
Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer’s disease: possible influence of treatment. New Eng J Med 313:7–11
Gaëta BA, Borthwick I, Stanley KK (1994) The 5′-flanking region of the alpha 2MR/LRP gene contains an enhancer-like cluster of Sp1 binding sites. Biochim Biophys Acta 1219:307–313
Gaultier A, Simon G, Niessen S, Dix M, Takimoto S, Cravatt BF 3rd, Gonias SL (2010) LDL receptor-related protein 1 regulates the abundance of diverse cell-signalling proteins in the plasma membrane proteome. J Proteome Res 9:6689–6695. doi:10.1021/pr1008288
Haby C, Lisovoski F, Aunis D, Zwiller J (1994) Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and junB in PC12 cells. J Neurochem 62:496–501
Hayashi H, Campenot RB, Vance DE, Vance JE (2007) Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1. J Neurosci 27:1933–1941
Herz J, Beffert U (2000) Apolipoprotein E receptors: linking brain development and Alzheimer’s disease. Nat Rev Neurosci 1:51–58
Herz J, Strickland DK (2001) LRP: a multifunctional scavenger and signalling receptor. J Clin Invest 108:779–784
Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK (1988) Surface location and high affinity for calcium of a 500-kD liver membrane protein closely related to the LDL-receptor suggests a physiological role as a lipoprotein receptor. EMBO J 7:4119–4127
Herz J, Kowal RC, Goldstein JL, Brown MS (1990) Proteolytic processing of the 600 kd low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment. EMBO J 9:1769–1776
Hu L, Boesten LS, May P, Herz J, Bovenschen N, Huisman MV, Berbee JF, Havekes LM, van Vlijmen BJ, Tamsa JT (2006) Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice. Arterioscler Trhomb Vasc Bio 26:2710–2715
Ishiguro M, Imai Y, Kohsaka S (1995) Expression and distribution of low density lipoprotein receptor-related protein mRNA in the rat central nervous system. Brain Res Mol Brain Res 33:37–46
Kalisch BE, Bock NA, Davis W, Rylett RJ (2002) Inhibitors of nitric oxide synthase attenuate nerve growth factor-mediated increases in choline acetyltransferase gene expression in PC12 cells. J Neurochem 81:624–635
Kalisch BE, Demeris CS, Rylett RJ (2003) Modulation of nerve growth factor-induced activation of MAP kinase in PC12 cells by inhibitors of nitric oxide synthase. J Neurohem 87:1321–1332
Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R, Koo EH (2000) Modulation of amyloid beta-protein clearance and Alzheimer’s disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 106:1159–1166
Kanterewicz BI, Knapp LT, Klann E (1998) Stimulation of p42 and p44 mitogen-activated protein kinases by reactive oxygen species and nitric oxide in hippocampus. J Neurochem 70:1009–1016
Kato A, Endo T, Abiko S, Ariga H, Matsumoto K (2008) Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions. Exp Cell Res 314:2661–2673
Khavandgar S, Homayoun H, Dehpour AR (2003) Mediation of nitric oxide in inhibitory effect of morphine against electroshock-induced convulsions in mice. Pharmacol Biochem Behav 74:795–801
Knisely JM, Lee J, Bu G (2008) Measurement of receptor endocytosis and recycling. Methods Mol Biol 457:319–332
Kumahara E, Ebihara T, Saffen D (1999) Nerve growth factor induces zif268 gene expression via MAPK-dependent and -independent pathways in PC12D cells. J Biochem 125:541–553
Lee SB, Rhee SG (1995) Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. Curr Opin Cell Biol 7:183–189
Lee SJ, Park SS, Cho YH, Park K, Kim EJ, Jung KH, Kim SK, Kim WJ, Moon SK (2008) Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways. Oncol Rep 19:1007–1013
Liang M, Knox FG (1999) Nitric oxide activates PKCalpha and inhibits Na+-K+-ATPase in opossum kidney cells. Am J Physiol 277(6 Pt 2):F859–F865
Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK (2008) LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 88:887–918
Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, Cole SL, Herz J, Muglia L, Bu G (2007) Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56:66–78
Lorent K, Overbergh L, Moechars D, DeStrooper B, Van Leuven F, Van den Berghe H (1995) Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the alpha-2-macrogobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein R, lipoprotein lipase, alpha-2-macrogobulin and the 40,000 molecular weight receptor-associated protein. Neuroscience 65:1009–1025
Loukinova E, Ranganathan S, Kuznetsov S, Gorlatov N, Migliorinin MM, Loukinov D, Ulery PG, Mikhailenki I, Lawrence DA, Strickland DK (2002) PDGF-induced tyrosine phosphorylation of the LDL receptor-related protein (LRP): evidence for the integrated co-receptor function between LRP and the PDGF receptor. J Biol Chem 277:15499–15506
MacKinnon JC, Huether P, Kalisch BE (2012) Effects of nerve growth factor and nitric oxide synthase inhibitors on amyloid precursor protein mRNA levels and protein stability. Open Biochem J 6:31–39. doi:10.2174/1874091X012060100031
Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622–630
Shi Y, Mantuano, E, Inoue G, Campana WM, Gonias SL (2009) Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci Signal 2:ra18. doi:10.1126/scisignal.2000188
Martin AM, Kuhlman C, Trossbach S, Jaeger S, Waldron E, Roebroek A, Luhmann HJ, Laatsch A, Weggen S, Lessmann V, Pietrzik CU (2008) The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of the N-methyl-d-aspartate receptors. J Biol Chem 283:12004–12013
Milward EA, Papadopoulos R, Fuller SJ, Moir RD, Small D, Beyreuther K, Masters CL (1992) The amyloid protein precursor of Alzheimer’s disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9:129–137
Morris BJ (1995) Stimulation of immediate early gene expression in striatal neurons by nitric oxide. J Biol Chem 270:24740–24744
Narita M, Bu G, Holtzman DM, Schwartz AL (1997) The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J Neurochem 68:587–595
Nathan BP, Jian Y, Wong GK, Shen F, Brewer GJ, Struble RG (2002) Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res 928:96–105
Olson L, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A et al (1992) Nerve growth factor affects 11C-nicotine binding, blood flow, EEG and verbal episodic memory in an Alzheimer patient (case report). J Neural transm Park Dement Sect 4:79–95
Park KM, Yule DI, Bowers WJ (2009) Tumor necrosis factor-alpha-mediated regulation of the inositol 1,4,5-trisphosphate receptor promoter. J Biol Chem 284:27557–27566
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Mol Brain Res 1:53–62
Peunova N, Enikolopov G (1995) Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375:68–73
Pietrzik CU, Busse T, Merriam DE, Weggen S, Koo EH (2002) The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J 21:5691–5700
Pilz RB, Suhasini M, Idriss S, Meinkoth JL, Boss GR (1995) Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J 9:552–558
Postuma RB, Martins RN, Cappai R, Bevreuther K, Masters CL, Strickland DK, Mok SS, Small DH (1998) Effects of the amyloid protein precursor of Alzheimer’s disease and other ligands of the LDL receptor-related protein on neurite outgrowth from sympathetic neurons in culture. FEBS Lett 428:13–16
Qiu Z, Strickland DK, Hyman BT, Rebeck GW (1999) Alpha2-macroglonbulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J Neurochem 73:1393–1398
Qiu Z, Hyman BT, Rebeck GW (2004) Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons. J Biol Chem 279:34948–34956
Rebeck GW, Harr SD, Strickland DK, Hyman BT (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobuline receptor/low-density-lipoprotein receptor-related protein. Ann Neurol 37:211–217
Seiger A, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A et al (1993) Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav Brain Res 57:255–261
Sellak H, Yang X, Cao X, Cornwell T, Soff GA, Lincoln T (2002) Sp1 transcription factor as a molecular target for nitric oxide- and cyclic nucleotide-mediated suppression of cGMP-dependent protein kinase-Ialpha expression in vascular smooth muscle cells. Circ Res 90:405–412
Sheehy AM, Phung YT, Riemer RK, Black SM (1997) Growth factor induction of nitric oxide synthase in rat pheochromocytoma cells. Brain Res Mol Brain Res 52:71–77
Smith AR, Hagen TM (2003) Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid. Biochem Soc Trans 31(Pt 6):1447–1449
Southan GJ, Szabo C, Thiemermann C (1995) Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114:510–516
Strada O, Vyas S, Hirsch EC, Ruberg M, Brice A, Agid Y, Javoy-Agid F (1992) Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study. Proc Natl Acad Sci USA 89:9549–9553
Strickland DK, Kounnas MZ, Argraves WS (1995) LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 9:890–898
Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, Strickland DK (2000) Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer’s disease. J Biol Chem 275:7410–7415
Van der Zee A, Stas L, Hilleker C, van Leuven F, van Dijk KW, Havekes L, Frants R, Hofker M (1994) Genomic cloning of the mouse LDL receptor related protein/alpha 2-macroglobulin receptor gene. Genomics 23:256–259
Van Uden E, Kang DE, Koo EH, Masliah E (2000) LDL receptor-related protein (LRP) in Alzheimer’s disease: towards a unified theory of pathogenesis. Micros Res Tech 50:268–272
Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, White CL, Parhad IM, Price DL (1983) Neuroanatomical evidence for a cholinergic deficit in Alzheimer’s disease. Psychopharmacol Bull 19:437–440
Winick-Ng W, Leri F, Kalisch BE (2012) Nitric oxide and histone deacetylases modulate cocaine-induced mu-opioid receptor levels in PC12 cells. BMC Pharmacol 18:11
Wolf BB, Lopes MBS, VandenBerg SR, Gonias SL (1992) Characterization and immunohistochemical localization of α2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol 141:37–42
Wooten MW, Seibenhener ML, Zhou G, Vandenplas ML, Tan TH (1999) Overexpression of atypical PKC in PC12 cells enhances NGF-responsiveness and survival through an NF-kappaB dependent pathway. Cell Death Differ 6:753–764
Zerbinatti CV, Wozniak DF, Cirrito J, Cam JA, Osaka H, Bales KR, Zhuo M, Paul SM, Holtzman DM, Bu G (2004) Increased soluble amyloid-β peptide and memory deficits in amyloid model mice overexpression the low-density lipoprotein receptor related protein. Proc Natl Acad Sci USA 101:1075–1080
Zhang P, Wang YZ, Kagan E, Bonner JC (2000) Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J Biol Chem 275:22479–22486
Acknowledgments
These studies were supported by an operating grant from the Natural Sciences and Engineering Research Council of Canada to BEK and an Ontario Graduate Scholarship to TRG.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grana, T.R., LaMarre, J. & Kalisch, B.E. Nerve Growth Factor-Mediated Regulation of Low Density Lipoprotein Receptor-Related Protein Promoter Activation. Cell Mol Neurobiol 33, 269–282 (2013). https://doi.org/10.1007/s10571-012-9894-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-012-9894-3